EGFR and KRAS mutational analysis in a large series of Italian non-small cell lung cancer patients: 2,387 cases from a single center

This publication has 20 references indexed in Scilit:

• Routine EGFR Molecular Analysis in Non-Small-Cell Lung Cancer Patients is Feasible: Exons 18–21 Sequencing Results of 753 Patients and Subsequent Clinical Outcomes
  Lung, 2013
• The frequency of EGFR and KRAS mutations in non-small cell lung cancer (NSCLC): routine screening data for central Europe from a cohort study
  BMJ Open, 2013
• Molecular Pathology of Non–Small Cell Lung Cancer
  American Journal of Clinical Pathology, 2012
• Squamous Cell Carcinoma of the Lung: Molecular Subtypes and Therapeutic Opportunities
  Clinical Cancer Research, 2012
• EGFR and KRAS mutations in lung carcinomas in the Dutch population: increased EGFR mutation frequency in malignant pleural effusion of lung adenocarcinoma
  Cellular Oncology, 2012
• EGFR Gene Alterations in a Norwegian Cohort of Lung Cancer Patients Selected for Surgery
  Journal of Thoracic Oncology, 2011
• EGFR gene status in cytological samples of nonsmall cell lung carcinoma
  Cancer Cytopathology, 2011
• EGFR mutation detection in NSCLC—assessment of diagnostic application and recommendations of the German Panel for Mutation Testing in NSCLC
  Virchows Archiv, 2010
• Biomarkers of Response to Epidermal Growth Factor Receptor Inhibitors in Non–Small-Cell Lung Cancer Working Group: Standardization for Use in the Clinical Trial Setting
  Journal of Clinical Oncology, 2008
• EGFR Mutations in Non–Small-Cell Lung Cancer: Analysis of a Large Series of Cases and Development of a Rapid and Sensitive Method for Diagnostic Screening With Potential Implications on Pharmacologic Treatment
  Journal of Clinical Oncology, 2005